Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Catvira vs SOF+RBV in Genotype 4 HCV
NCT02483156Phase 3Completed
- Sponsor
- Egyptian Liver Hospital
- Start
- Jul 2015
- Primary completion
- Aug 2015
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of epigallocatechin gallate in hepatitis C (HCV), sponsored by Egyptian Liver Hospital. Started Jul 2015; status: completed.
02
Drugs
epigallocatechin gallate
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02483156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02483156.